Related Article

This CCR Translation refers to the following article:
Quantitative ER and PgR Assessment as Predictors of Benefit from Lapatinib in Postmenopausal Women with Hormone Receptor�Positive, HER2-Negative Metastatic Breast Cancer
Richard S. Finn, Michael F. Press, Judy Dering, Lisa O'Rourke, Allison Florance, Catherine Ellis, Anne-Marie Martin, and Stephen Johnston